COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $682,420 | +341.9% | 182,465 | +404.5% | 0.00% | – |
Q2 2023 | $154,425 | -73.6% | 36,165 | -57.7% | 0.00% | – |
Q1 2023 | $584,656 | +1221.3% | 85,476 | +1429.9% | 0.00% | – |
Q4 2022 | $44,249 | -51.9% | 5,587 | -41.6% | 0.00% | – |
Q3 2022 | $92,000 | +17.9% | 9,560 | -10.7% | 0.00% | – |
Q2 2022 | $78,000 | -84.8% | 10,710 | -72.9% | 0.00% | – |
Q1 2022 | $512,000 | -47.2% | 39,549 | -34.9% | 0.00% | – |
Q4 2021 | $969,000 | -57.2% | 60,712 | -56.9% | 0.00% | – |
Q3 2021 | $2,263,000 | -34.2% | 140,829 | -43.3% | 0.00% | -100.0% |
Q2 2021 | $3,437,000 | -5.9% | 248,535 | -0.6% | 0.00% | 0.0% |
Q1 2021 | $3,651,000 | -34.7% | 249,940 | -22.3% | 0.00% | 0.0% |
Q4 2020 | $5,592,000 | -24.3% | 321,765 | -20.1% | 0.00% | -50.0% |
Q3 2020 | $7,388,000 | +5.4% | 402,793 | +2.6% | 0.00% | 0.0% |
Q2 2020 | $7,011,000 | +13.4% | 392,543 | +3.0% | 0.00% | 0.0% |
Q1 2020 | $6,183,000 | -30.9% | 381,289 | -23.3% | 0.00% | 0.0% |
Q4 2019 | $8,947,000 | +12.3% | 496,959 | +26.4% | 0.00% | 0.0% |
Q3 2019 | $7,968,000 | +36.0% | 393,301 | +48.4% | 0.00% | 0.0% |
Q2 2019 | $5,858,000 | +60.4% | 265,023 | -1.1% | 0.00% | +100.0% |
Q1 2019 | $3,653,000 | +50.3% | 267,839 | -0.2% | 0.00% | 0.0% |
Q4 2018 | $2,430,000 | -44.2% | 268,416 | +1.6% | 0.00% | 0.0% |
Q3 2018 | $4,358,000 | +26.7% | 264,068 | +7.5% | 0.00% | 0.0% |
Q2 2018 | $3,440,000 | +42.6% | 245,755 | +12.5% | 0.00% | 0.0% |
Q1 2018 | $2,413,000 | +28.8% | 218,448 | +2.7% | 0.00% | 0.0% |
Q4 2017 | $1,873,000 | -8.9% | 212,790 | +38.2% | 0.00% | 0.0% |
Q3 2017 | $2,056,000 | +391.9% | 154,026 | +429.0% | 0.00% | – |
Q2 2017 | $418,000 | -31.6% | 29,116 | +0.9% | 0.00% | – |
Q1 2017 | $611,000 | -4.1% | 28,863 | +27.6% | 0.00% | – |
Q4 2016 | $637,000 | +77.9% | 22,618 | +69.3% | 0.00% | – |
Q3 2016 | $358,000 | +76.4% | 13,360 | +11.3% | 0.00% | – |
Q2 2016 | $203,000 | -28.3% | 12,006 | -9.8% | 0.00% | – |
Q1 2016 | $283,000 | +38.0% | 13,317 | +49.1% | 0.00% | – |
Q4 2015 | $205,000 | +115.8% | 8,929 | +88.6% | 0.00% | – |
Q3 2015 | $95,000 | -39.9% | 4,734 | -13.4% | 0.00% | – |
Q2 2015 | $158,000 | +690.0% | 5,464 | +705.9% | 0.00% | – |
Q1 2015 | $20,000 | – | 678 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |